Autopsy report · NCT03483181

Thromboprophylaxis in Patients Undergoing Orthopedic Surgeries; Using Propensity Score Matching

“After further evaluation, the secondary data source was determined to be insufficient to address the study objectives. No prospective patient enrollment was planned, and the study was not initiated.”

The sponsor’s own words in the registry.

Life of this trial

• Withdrawn before it enrolled anyone. Its dates are the sponsor's plans, not events that happened.

Vital statistics

Status

Withdrawn

Sponsor

Hanoi Medical University

Sponsor type

University, hospital or other

Conditions

Thrombosis; Deep Vein Thrombosis; Surgery--Complications

Interventions

Xarelto (rivaroxaban); Lovenox (enoxaparin)

Participants

0

Sites

1

Countries

Vietnam

Trials that died the same way

• Accuracy of Robotically Assisted Cranial Biopsies
  “The clinical study could not be commenced due to the Principal Investigator's limited availability, which has significantly impacted the feasibility of continuing the study as planned. No safety concerns or adverse events were detected.” (65% match in meaning)
• Linifanib in Treating Patients With Advanced, Refractory Colorectal Cancer
  “Interim analysis determined the study did not meet criteria to proceed” (65% match in meaning)
• Ritonavir and Lopinavir in Treating Patients With Progressive or Recurrent High-Grade Glioma
  “Study did not meet its primary objective” (64% match in meaning)
• Effect of an Intervention Based on Back School in an Aquatic Environment on Non-specific Low Back Pain
  “The study was not initiated following an investigator decision not to proceed; no participants were enrolled.” (64% match in meaning)
• A Study of Ustekinumab in Participants With Active Polymyositis and Dermatomyositis Who Have Not Adequately Responded to One or More Standard-of-care Treatments
  “The study did not meet the primary endpoint.” (64% match in meaning)

Look deeper

• The official registry record (the source of truth)
• Record history: every change the sponsor made
• Open it in the database

Everything here comes from the current ClinicalTrials.gov record. The timeline uses the record’s dates; dates marked planned are the sponsor’s plans. The cause of death is an automatic, unverified label. This is research information, not medical advice.